Jin Lizi, Tang Wenyi, Song Lizheng, Luo Liyun, Zhou Zhijuan, Fan Xiuwu, Zhang Jinyou, Wu Niujian, Liu Kan, Chen Jian
Department of Cardiovascular Medicine, Fifth Affiliated Hospital of Sun Yat-sen University, Zhuhai, China.
Division of Cardiology, University of Iowa, Iowa City, IA 52240, USA.
Cardiovasc Diagn Ther. 2020 Oct;10(5):1303-1312. doi: 10.21037/cdt-20-607.
Coronavirus disease 2019 (COVID-19) has already became a public health emergency of international concern. COVID-19 related cardiac injury remains largely unclear.
We retrospectively analyzed demographic, clinical, laboratory and cardiovascular imaging data of all consecutively admitted adult COVID-19 patients in Zhuhai, China from January 17th, 2020 to February 18th, 2020.
A total of 93 patients were included in the study. Acute cardiac injury was found in 9 (9.7%) COVID-19 patients with median level of hypersensitive cardiac troponin I (hs-cTnI) to be 0.085 µg/L (IQR 0.027-0.560 µg/L). Compared with patients without cardiac injury, the median age of patients with cardiac injury was significantly older (65.0 44.0, P<0.05), hypertension was significantly more common (44.4% 14.3%, P<0.05), and the proportion of severe-critical cases were greater (77.8% 17.9%, P<0.05). Patients with cardiac injury were more likely have elevation of N-terminal proBNP (NT-proBNP) in comparison (66.7% 10.0%, P<0.05). There was no significant difference in echocardiographic parameters between patients with and without cardiac injury. Multivariable logistic regression analysis indicated that older age (OR: 1.093, 95% CI: 1.011-1.182) and increased NT-proBNP (OR: 10.979, 95% CI: 2.024-59.555) were independent risk factors for cardiac injury. Cardiac magnetic resonance (CMR) imaging performed on three patients at around one month after they underwent significant hs-cTnI elevation showed that they had underlying cardiovascular comorbidities.
Acute cardiac injury was seen in the minority of hospitalized COVID-19 patients in Zhuhai, China. Older age and increased NT-proBNP were associated with acute cardiac injury.
ChiCTR2000030952.
2019冠状病毒病(COVID-19)已成为国际关注的突发公共卫生事件。COVID-19相关的心脏损伤在很大程度上仍不清楚。
我们回顾性分析了2020年1月17日至2020年2月18日在中国珠海连续收治的所有成年COVID-19患者的人口统计学、临床、实验室和心血管影像学数据。
本研究共纳入93例患者。9例(9.7%)COVID-19患者出现急性心脏损伤,超敏心肌肌钙蛋白I(hs-cTnI)中位数水平为0.085μg/L(四分位间距0.027 - 0.560μg/L)。与无心脏损伤的患者相比,有心脏损伤的患者中位年龄显著更大(65.0对44.0,P<0.05),高血压更为常见(44.4%对14.3%,P<0.05),重症病例比例更高(77.8%对17.9%,P<0.05)。有心脏损伤的患者N末端脑钠肽前体(NT-proBNP)升高的可能性更大(66.7%对10.0%,P<0.05)。有心脏损伤和无心脏损伤的患者之间超声心动图参数无显著差异。多变量逻辑回归分析表明,年龄较大(比值比:1.093,95%置信区间:1.011 - 1.182)和NT-proBNP升高(比值比:10.979,95%置信区间:2.024 - 59.555)是心脏损伤的独立危险因素。在3例hs-cTnI显著升高后约1个月进行心脏磁共振(CMR)成像检查的患者显示他们存在潜在的心血管合并症。
在中国珠海,少数住院COVID-19患者出现急性心脏损伤。年龄较大和NT-proBNP升高与急性心脏损伤有关。
ChiCTR2000030952。